What you need to know about Histallay
This content is produced in partnership with Histallay
On December 22, 2020 the Medicines Healthcare and Regulatory Authority (MHRA) published a public assessment report reclassifying fexofenadine 120mg tablets from a prescription only medicine (POM) to general sales list (GSL). Fexofenadine is a non-sedating antihistamine, used to relieve symptoms of allergy such as hayfever, blocked nose and itchy or watery eyes.
Complete this CPD on the C+D Community
https://community.chemistanddruggist.co.uk/posts/cpd-module-fexofenadine?room_id=4400